ticlopidine has been researched along with Leriche Syndrome in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Leriche Syndrome: A condition caused by occlusion of terminal aorta, the primary branches of the ABDOMINAL AORTA, as in aortoiliac obstruction. Leriche syndrome usually occurs in males and is characterized by IMPOTENCE, absence of a pulse in the femoral arteries, weakness and numbness in the lower back, buttocks, hips, and lower limbs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirichenko, AA | 1 |
| Prekina, VI | 1 |
| Repinskaia, NP | 1 |
| Novichkova, IuN | 1 |
| Ter-Gevondian, NM | 1 |
| Vinogradova, IV | 1 |
1 other study available for ticlopidine and Leriche Syndrome
| Article | Year |
|---|---|
[The efficacy of ticlid in treating intermittent claudication in atherosclerotic stenosis of the arteries of the lower extremities].
Topics: Adult; Arteriosclerosis; Blood Coagulation Tests; Hemostasis; Humans; Intermittent Claudication; Leg | 1994 |